FDA Inspection
Octapharma plasmaOctapharma plasma – FDA Inspection, Feb 8, 2012
Record Details
This FDA Inspection record concerns Octapharma plasma, with an inspection on February 8, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma plasma
- Inspection Date
- February 8, 2012
- Product Type
- Biologics
View Company Profile
ID · 39d4fba5-d68f-4002-88c1-0cf936834485
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 771601
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma plasma
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2026 | Not classified | Atlanta District Office | |
| March 1, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 29, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 19, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma plasma
- FDA Inspection 1304042 - 2026-01-21
- FDA Inspection 1043453 - 2018-03-01
- FDA Inspection 897806 - 2014-09-29
- FDA Inspection 676545 - 2010-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.